Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by CDJ9292on Apr 08, 2018 3:01pm
185 Views
Post# 27849837

RE:RE:RE:Anyone still hoping for a short squeeze.

RE:RE:RE:Anyone still hoping for a short squeeze.
37minus4 wrote: Culiabria,

That’s why you need to stick with the institutions (they’re buying now) and not follow the lemming retailers off the cliff (selling off while believing the “this is going to zero” basher gang).

RBC and TD are calling $2. 

CIBC and National continue to endeavour to destroy this company for their reasons or those of their American employers.

Still oversold.

33



The last thing you should ever do is listen to this guy. He has been wrong for 3 years in a row and is way too emotionally invested in PLI, as are many others here. 
Bullboard Posts